Ep200: Richard Pops Reflects on a 35-Year Career in Biotech
May 5, 2026 · 1 h 14 min
Show notes
Alkermes CEO Richard Pops reflects on his 35-year career leading the company and its new opportunity in orexin biology for sleep disorders and more neurological conditions.